Reliance Industries has approved plans to raise up to Rs 15,000 crore through non-convertible debentures via private placement. The fundraising announcement came with the company's Q2 earnings where it reported a 41% year-on-year rise in net profit to Rs 25,548 crore.

Reliance Retail Q2 Results: The company's gross revenue increased 6.4% YoY to Rs 91,716 crore in Q2FY27, compared with Rs 86,169 crore in the year-ago period. The growth came despite the absence of major festive occasions during the quarter, with the festive calendar shifting to the December quarter.

Reliance Industries reported record Q2FY27 profit of Rs 29,550 crore and revenue of Rs 3.62 lakh crore, driven by strong refining margins and Jio growth. Retail profitability weakened, while declining debt improved the conglomerate's financial position.

Bank of Baroda reported 36% year-on-year profit growth to Rs 6,532 crore in Q2FY27, boosted by NSE stake sale gains and higher interest income. The lender raised annual credit and deposit growth guidance amid strong loan demand.

Spandana Sphoorty Financial reported consolidated Q2 profit of Rs 18 crore, reversing a Rs 249 crore year-ago loss. Assets under management grew 31% to Rs 5,364 crore, while improving asset quality reduced gross and net NPAs.

Lodha Developers reported a 63% rise in first-half FY27 profit to Rs 2,386 crore, driven by strong property sales and market expansion. The developer expects to exceed annual profit guidance while pursuing data centres to boost recurring income.

Zee Entertainment Enterprises reported a 40% decline in consolidated net profit for the quarter ended September 30, 2026. Operating revenue increased by 13%, largely due to growth in subscription revenue supported by the FIFA World Cup 2026. Total expenditure rose by 18% primarily driven by increased programming and promotional costs. ZEE5, the company's streaming platform, showed significant growth by doubling its revenue year-on-year.

Syrma SGS Technology reported an 87.2% increase in consolidated net profit for the quarter ending September 2026. Consolidated revenue increased by 73.2%, reaching a record high of Rs 1,999.5 crore. The company’s exports grew by 91% year-on-year, showcasing strong international demand. Investments are planned in collaboration with Kaga Electronics to enhance the domestic supply ecosystem.

Sun Pharma reported a 36% decline in Q2FY27 net profit to Rs 1,989 crore due to exceptional litigation and acquisition-related costs. Revenue grew 11.8%, supported by strong domestic and emerging market sales, while US formulations weakened.